EGFR and lung carcinoma: For example, microtubule inhibition caused inactivation of the EGFR receptor in specific cancer types [62] and caused resensitization of resistant lung cancer cell lines to EGFR inhibitors, suggesting a synergistic effect for both drugs [63].